EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has announced its participation in the CJS 25th Annual “New Ideas for the New Year” Virtual Investor Conference. The presentation is scheduled for January 14, 2025, at 10:15 a.m. ET.
Representing the company at the event will be Cindy Reiss-Clark, Senior Vice President and Chief Commercial Officer; Chad Winters, Vice President of Finance and Chief Accounting Officer; and John Sweeney, Vice President of Investor Relations. This leadership team will provide insights into West’s performance and future plans, offering investors a closer look at the company’s strategy and market positioning.
West, headquartered in Exton, Pennsylvania, has consistently demonstrated strong financial performance. For fiscal year 2023, the company reported $2.95 billion in net sales, underscoring its prominence in the healthcare industry and its position as a key player in the Standard & Poor’s 500 index.
The presentation is expected to highlight West’s financial stability, innovative product portfolio, and commitment to addressing the evolving needs of the pharmaceutical and healthcare sectors.
West Pharmaceutical Services continues to set industry benchmarks through its focus on quality and innovation, including advanced drug delivery systems. Its participation in the CJS conference aims to reinforce its ongoing engagement with the investor community.
An audio webcast of the presentation will be accessible through the Investors section of the company’s website. Investors and analysts are anticipated to gain valuable insights into West’s future objectives and market opportunities.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.